Analyst consensus rating
Hinge Health Analyst Rating: Buy
Direct answer
Hinge Health's consensus rating is Buy.
15 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $108.07.
Forecast evidence checked September 23, 2026.
Get free Hinge Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $91.20
- Average price target
- $108.07
- High price target
- $140.00
- Low price target
- $90.00
- Low target gap
- -1.3%
- Target upside
- +18.5%
- High target gap
- +53.5%
- Target range width
- 54.8%
- Consensus rating
- Buy
- Analysts
- 15
- Evidence date
- September 23, 2026
- Valid through
- September 30, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Hinge Health?
Hinge Health has a verified Buy consensus. The same dataset has an average price target of $108.07.
How far are Hinge Health's low and high targets from the recorded price?
The low target implies -1.3%, while the high target implies +53.5%.
How many analysts are included in Hinge Health's consensus?
The verified consensus includes 15 analysts.
How is Hinge Health's target upside or downside calculated?
The average target of $108.07 is divided by the recorded price of $91.20, then one is subtracted to produce +18.5%. This does not guarantee a future return.
When was Hinge Health's analyst forecast verified?
The data was verified on 2026-09-23. The dataset is valid through 2026-09-30.